Abbott Laboratories is a globally recognized healthcare company that provides a broad and diversified line of health care products. Abbott operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Founded by Dr. Wallace Calvin Abbott in 1888, this healthcare pioneer has established its global headquarters in North Chicago, Illinois, United States, where it continues to focus on delivering life-changing technologies that keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines, and breakthroughs to manage your health.
Main Product(s):
Abbott Laboratories is known for its diverse range of medical devices, diagnostic tests and instruments, nutritional products for infants, children, and adults, and branded generic pharmaceuticals.
Short History of Abbott Laboratories:
1888 – Dr. Wallace C. Abbott founded the company in Chicago, establishing the Abbott Alkaloidal Company.
1915 – Abbott expanded its product line and global reach, beginning operations in Canada, the United Kingdom, and Australia.
1964 – The company officially changed its name to Abbott Laboratories.
1985 – Abbott developed the first-ever HIV blood screening test.
2001 – The company spun off its hospital products division as Hospira.
2013 – Abbott spun off its research-based pharmaceuticals business, creating a new company, AbbVie Inc.
2020 – Abbott played a significant role in the development and distribution of COVID-19 rapid testing solutions.
Key Executives:
Name
Title
Pay
Exercised
Year Born
Mr. Robert B. Ford
Chairman of the Board, President & CEO
4.05M
6.64M
1974
Mr. Hubert L. Allen
Executive VP, General Counsel & Secretary
2.01M
N/A
1966
Mr. Robert E. Funck Jr.
Executive Vice President of Finance
2.16M
N/A
1961
Mr. Daniel Gesua Sive Salvadori
Executive VP and Group President of Established Pharmaceuticals & Nutritional Products
1.49M
N/A
1979
Ms. Andrea F. Wainer
Executive Vice President of Rapid & Molecular Diagnostics
1.75M
N/A
1970
Mr. Philip P. Boudreau
CFO & Senior VP of Finance
N/A
N/A
1973
Erica L. Battaglia
VP and Chief Ethics & Compliance Officer
N/A
N/A
N/A
Ms. Melissa Brotz
Vice President of Public Affairs & Corporate Marketing